Latifi B: Infections in neutropenic patients; case presentation

Scherz V: Infections in neutropenic patients; overview

Köhn F: Antibacterial prophylaxis with quinolones: yes or no?

Giannini A: Universal prophylaxis vs. pre-emptive approach against fungal infections

Vouloagka A: Discontinuation of antibiotic therapy: Can antibiotics be stopped in a neutropenic patient under some circumstances?

Staiger W: Infections in solid organ transplant recipients; case presentation

Lippmann J: Infections in solid organ transplant recipients; overview

Wettstein S: Asymptomatic bacteriuria in kidney transplant recipients: to treat or not?

Tallon de Lara C: CMV management: prophylaxis vs. preemptive approach 

Schumacher M: Secondary prophylaxis against PJP after first episode: yes or no? If yes, how long?

Bellini P: Fever of unknown origin; case presentation

Simon N: Fever of unknown origin; structured approach

Friedrich B: Is there still a role for patient history in FUO?

Ruiz Arabi E: Should a PET-CT scan be performed as first line radiological diagnostic step 

Mertelsmann A: What is the role of AI in the diagnostic process?

Latifi B: Infections in neutropenic patients; case presentation

Scherz V: Infections in neutropenic patients; overview

Köhn F: Antibacterial prophylaxis with quinolones: yes or no?

Giannini A: Universal prophylaxis vs. pre-emptive approach against fungal infections

Vouloagka A: Discontinuation of antibiotic therapy: Can antibiotics be stopped in a neutropenic patient under some circumstances?

Staiger W: Infections in solid organ transplant recipients; case presentation

Lippmann J: Infections in solid organ transplant recipients; overview

Wettstein S: Asymptomatic bacteriuria in kidney transplant recipients: to treat or not?
Tallon de Lara C: CMV management: prophylaxis vs. preemptive approach
Schumacher M: Secondary prophylaxis against PJP after first episode: yes or no? If yes, how long?

Bellini P: Fever of unknown origin; case presentation

Simon N: Fever of unknown origin; structured approach

Friedrich B: Is there still a role for patient history in FUO?
Ruiz Arabi E: Should a PET-CT scan be performed as first line radiological diagnostic step 
Mertelsmann A: What is the role of AI in the diagnostic process?

Lauren Clack, University of Zurich

Moderation: 
Laurence Senn, CHUV Lausanne

Slides

Webcast

Speaker: Silvio Brugger, University Hospital Zurich

Moderator: Pauline Vetter, University Hospital Geneva

Slides

Webcast

Dominique Blanc, CHUV Lausanne

Moderation: 
Niccolò Buetti, University Hospital Geneva

Slides

Webcast

Speakers and moderators
Baharak Babouee Flury, Cantonal Hospital St. Gallen
Diego Andrey, University Hospital Geneva

Slides

Webcast

Speaker: Brad Spellberg, Los Angeles General Medical Center, USA

Moderator: Philipp Jent, Inselspital Berne

Slides

Webcast

Delphine Berthod, Hôpitaux du Valais

Gaud Catho, Hôpitaux du Valais

Benedikt Wiggli, Cantonal Hospital Baden

Moderation: 
Laurence Senn, CHUV Lausanne

Slides

Webcast

Speaker: Blerina Latifi, Inselspital Bern

Moderator: Eloïse Magnenat, Inselspital Bern

Speakers

Pauline Vetter, Geneva University Hospital

Walter Zingg, Zürich University Hospital

Moderator: Dionysios Neofytos, Geneva University Hospital

Slides Vetter

Slides Zingg

Webcast

Delphine Berthod, Hôpitaux du Valais

Aline Wolfensberger, University Hospital Zurich

Moderation: 
Laurence Senn, CHUV Lausanne

Slides

Webcast

Colin E.: Update Epidemiologie: Globale Trends – lokale Herausforderungen

Damonti L.: CRAB Ausbruch auf der Intensivstation – Lektionen für die Zukunft

Frick W., Bishtawi D.: Herausforderungen in Reinigung und Desinfektion, Inputreferat

Mutters N.: Herausforderungen der Infektionsprävention: Deutschland

Zingg W.: Herausforderungen der Infektionsprävention: Schweiz

Tschudin Sutter S.: Publikationshighlight Infektionsprävention

Colin E.: Update Epidemiologie: Globale Trends – lokale Herausforderungen

Damonti L.: CRAB Ausbruch auf der Intensivstation – Lektionen für die Zukunft

Frick W., Bishtawi D.: Herausforderungen in Reinigung und Desinfektion, Inputreferat

Mutters N.: Herausforderungen der Infektionsprävention: Deutschland

Zingg W.: Herausforderungen der Infektionsprävention: Schweiz

Tschudin Sutter S.: Publikationshighlight Infektionsprävention

Davis J: The SNAP example: Platform adaptive trial designs

Huttner A: Why do we need clinical trials in Switzerland? Investigator perspective

Nagy Bonnard L: Why do we need clinical trials in Switzerland? Patients' perspective

Speich B: Switzerland: a country of cohorts – The TWICS opportunity 

Tan R: Cluster randomized controlled trials: advantages and caveats 

Lassen M: The power of routine data: conducting the mega-Danish clinical trial 

Keitel K: Pragmatic clinical trial in low resource settings 

Bielicki J: Large consortia in clinical trials: Opportunities and challenges 

Davis J: The SNAP example: Platform adaptive trial designs

Huttner A: Why do we need clinical trials in Switzerland? Investigator perspective

Nagy Bonnard L: Why do we need clinical trials in Switzerland? Patients' perspective

Speich B: Switzerland: a country of cohorts – The TWICS opportunity 

Tan R: Cluster randomized controlled trials: advantages and caveats 

Lassen M: The power of routine data: conducting the mega-Danish clinical trial 

Keitel K: Pragmatic clinical trial in low resource settings 

Bielicki J: Large consortia in clinical trials: Opportunities and challenges 

Speakers: Johannes Nemeth, University Hospital Zurich
Marisa Kälin, University Hospital Zurich

Moderator: Lucas Boeck, University Hospital Basel

Slides

Webcast

Speaker: Eleftheria Kampouri, Service des maladies infectieuses, CHUV Lausanne

Niccolò Buetti, University Hospital Geneva

Andrea Büchler, CHUV Lausanne

Walter Zingg, University Hospital Zurich

Moderation: 
Niccolò Buetti, University Hospital Geneva

Slides

Webcast

Speaker: Sylvain Meylan, CHUV Lausanne

Moderator: Christine Thurnheer, Inselspital Bern

Slides

Webcast

Speaker: Adrian Martineau, Queen Mary University of London

Gaud Catho, Hôpitaux du Valais

Lauro Damonti, Inselspital Berne

Moderation: 
Niccolò Buetti, University Hospital Geneva

Slides

Webcast

Speaker: Roberta di Nicola, University Hospital Basel

Moderator: Nadine Bernasconi, University Hospital Basel

Tamó R: Diagnosis and treatment of native joint infections

Török J: Diabetic foot infections: duration of antibiotic treatment after amputation

Brahier Th: Indications for surgery in vertebral osteomyelitis 

Vouloagka A: Diagnostic criteria, classification and treatment of fracture-related infections 

Pallanza M: DAIR in prosthetic joint infections: indications and risk factors for failure

Valente L: The role and evidence of rifampicin in prosthetic joint infections

Schumacher M: Are antibiotics “holidays” necessary before re-implantation in two-stage exchange of a prosthetic joint infection?

Gubser P: Which antibiotics penetrate well into the bone - what is the evidence?

Dörr T: Classification of skin and soft tissue infections and their risk factors

Bock L: Antibiotic treatment duration of skin and soft tissue infection

Turicchi G: How to prevent recurrent cellulitis

Calame A: The returning traveler with a skin ulcer on the leg

Tamó R: Diagnosis and treatment of native joint infections

Török J: Diabetic foot infections: duration of antibiotic treatment after amputation

Brahier Th: Indications for surgery in vertebral osteomyelitis
Vouloagka A: Diagnostic criteria, classification and treatment of fracture-related infections
Pallanza M: DAIR in prosthetic joint infections: indications and risk factors for failure

Valente L: The role and evidence of rifampicin in prosthetic joint infections

Schumacher M: Are antibiotics “holidays” necessary before re-implantation in two-stage exchange of a prosthetic joint infection?

Gubser P: Which antibiotics penetrate well into the bone - what is the evidence?

Dörr T: Classification of skin and soft tissue infections and their risk factors

Bock L: Antibiotic treatment duration of skin and soft tissue infection

Turicchi G: How to prevent recurrent cellulitis

Calame A: The returning traveler with a skin ulcer on the leg

Speaker: Laura Walti, Inselspital Bern

Moderator: Eleftheria Kampouri, CHUV Lausanne

Slides

Webcast

Mohamed Abbas, University Hospital Geneva

Davide Bosetti, University Hospital Geneva

Sarah Tschudin Sutter, University Hospital Basel

Moderation: 
Laurence Senn, CHUV Lausanne
Niccolò Buetti, University Hospital Geneva

Slides

Webcast

Speakers & moderators:

Giacomo Stroffolini & Florian Tagini, CHUV Lausanne

Muller-Durovic B: Metabolic targets in EBV-infection

Hale B: Interferon autoantibodies

Renner E: Inborn immunodeficiencies and invasive infections

Jeker L: Targeting CD45 to replace the hematopoietic system for HIV eradication?

Rooijakkers S: Antibody-based Therapies for Infectious Diseases

Berney M: Innovation in Tuberculosis Drug Discovery and Development

Kouyos R: Primer: Mathematical Models in Infectious Diseases 

Opatowski L: Mathematical and Epidemiological Modeling of Antimicrobial Resistance Drivers

Perez L: Computational Vaccine Design

Mongiat M: Back to geography class

Berger Ch: Twins prematurely born due to an infection?

Gauthiez E: Horse or zebra?

Baumgartner Ch: Decompensated Cirrhosis: The Unusual Suspects

Marinosci A: Encephalitis at sixty-five

Frater J: Can T-cells confer sustained HIV suppression after bNAb therapy

Rutishauser R: Eliciting effective immune responses against HIV rebound

Trkola A: Multi-specificity is a common trait of HIV-1 broad neutralizing capacity

Feldman M: Biogenesis of extracellular vesicles in human gut bacteria

Valvano M: Intracellular persistence

Ramsey M: One (or two) ways in which bacterial commensals may prevent disease

Alimonti A: Microorganisms in oncogenesis and anti-cancer immune responses

Wong T: Diet-mediated immunometabolic regulation promotes Klebsiella pneumoniae airway clearance

Julian T: From clinical settings to wastewater systems

Schünemann V: Tracing pathogens through time with ancient DNA

Muller-Durovic B: Metabolic targets in EBV-infection 

Hale B: Interferon autoantibodies - slides not available

Renner E: Inborn immunodeficiencies and invasive infections 

Jeker L: Targeting CD45 to replace the hematopoietic system for HIV eradication? 

Rooijakkers S: Antibody-based Therapies for Infectious Diseases - slides not available

Berney M: Innovation in Tuberculosis Drug Discovery and Development - slides not available

Kouyos R: Primer: Mathematical Models in Infectious Diseases 

Opatowski L: Mathematical and Epidemiological Modeling of Antimicrobial Resistance Drivers 

Perez L: Computational Vaccine Design 

Mongiat M: Back to geography class

Berger Ch: Twins prematurely born due to an infection?

Gauthiez E: Horse or zebra? - slides not available

Baumgartner Ch: Decompensated Cirrhosis: The Unusual Suspects - slides not available

Marinosci A: Encephalitis at sixty-five

Frater J: Can T-cells confer sustained HIV suppression after bNAb therapy 

Rutishauser R: Eliciting effective immune responses against HIV rebound

Trkola A: Multi-specificity is a common trait of HIV-1 broad neutralizing capacity - slides not available

Feldman M: Biogenesis of extracellular vesicles in human gut bacteria

Valvano M: Intracellular persistence 

Ramsey M: One (or two) ways in which bacterial commensals may prevent disease 

Alimonti A: Microorganisms in oncogenesis and anti-cancer immune responses 

Wong T: Diet-mediated immunometabolic regulation promotes Klebsiella pneumoniae airway clearance 

Julian T: From clinical settings to wastewater systems 

Schünemann V: Tracing pathogens through time with ancient DNA - contact secretary@safe-id.ch for slides

Barbara Hasse, University Hospital Zürich

Madeleine Rothen, Board member SSI

Slides

Webcast

Gitzinger M: Herausforderungen der Antibiotikaforschung

Merz K: How infectious diseases meet pathology – Vorstellung des neuen Zentrums für Infektionsdiagnostik 

Bättig V, Schumacher M, Gürtler M, Erba A: Journal Club – Neues aus der Infektiologie

Skov R: Global implications of antimicrobial resistance

Kühl R: Was gibt es Neues zu Staphylococcus aureus-Bakteriämien?

Würfel E: Kontrolle übertragbarer Erkrankungen – eine Public-Health-Perspektive

Bassetti St, Keller P: Eine infektiologische Knacknuss

Gitzinger M: Herausforderungen der Antibiotikaforschung 

Merz K: How infectious diseases meet pathology – Vorstellung des neuen Zentrums für Infektionsdiagnostik  

Bättig V, Schumacher M, Gürtler M, Erba A: Journal Club – Neues aus der Infektiologie

Skov R: Global implications of antimicrobial resistance 

Kühl R: Was gibt es Neues zu Staphylococcus aureus-Bakteriämien?

Würfel E: Kontrolle übertragbarer Erkrankungen – eine Public-Health-Perspektive 

Bassetti St, Keller P: Eine infektiologische Knacknuss - nicht verfügbar

Speaker: Tamara Dörr, HOCH Health Ostschweiz St. Gallen

Moderator: David Weller, University Hospital Zürich

Slides

Laura Cordes Lourenço: Infections urinaires: une update

Mattéo Reymond: Infections sexuellement transmissibles

Alice Berger: Sinusite aiguë

Annabelle Roth: Pneumonie : diagnostic et traitement en charge ambulatoire

Manuel Schibler: SSI Guidelines: infection respiratoire aiguë et/ou syndrome grippal chez l’adulte

Romain Martischang: Vaccination contre: grippe, RSV, SARS-CoV-2: FAQs

Adrien Calame: Une molécule banale, une update extraordinaire